RAC 3.95% $1.46 race oncology ltd

General Comments / Chat, page-10127

  1. 204 Posts.
    lightbulb Created with Sketch. 66
    Anyone I’ve discussed RAC with that hasn’t bothered to dig any deeper or research themselves thinks I’m either high or having a stroke.

    I very much think a big part of RAC’s problem is the fact the opportunity is so big and so valuable. It gets even more crazy once you start joining the dots and realise just how de risked it is in comparison to other opportunities.

    If this is pulled off it will be one for the books, very much looking forward to RC220 data. If pharma don’t already have their snouts in the trough they ought to.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.